BioTrinity is a biopartnering & investment life sciences conference, that aims to shine a light on new innovation in the life sciences industry and inspire growth and create opportunities for all who attend.
In this session, CGT Catapult presents a series of exciting cell and gene therapy startup and spinout companies that are seeking investment to advance their novel technologies and therapies.
- iSTEM Therapeutics - presented by Peter Jones, Acting CEO
- NK:IO Ltd. - presented by Andrew Baxendale, COO
- Resolomics - presented by Jesmond Dalli, Founder, Director, and CSO
- Crucible Gene Therapeutics - presented by Thomas Bartlett, Knowledge Exchange & Commercialisation Manager, University of Sheffield
- VacV Biotherapeutics - presented by Louisa Chard, CTO
Hosted by Sam Goldsmith, Senior Commercialisation of Research Manager, CGT Catapult